Roswell_Park_Cancer_Institute_Corporation-DiaSorin_Molecular_LLC-2021-02-08T00:00:00.000

DiSorin Molecular LLC Simplexa Covid-19 Direct Kits and Controls KSS201211

New York State - Roswell Park Cancer Institute Corporation · NY, United States

View Source

Time Left to Bid

1566d 04h 09m

OpenOtherProvincial

Basic information

Reference number: Roswell_Park_Cancer_Institute_Corporation-DiaSorin_Molecular_LLC-2021-02-08T00:00:00.000
Issuing organization: New York State - Roswell Park Cancer Institute Corporation · Find award history →
Government level: Provincial
Solicitation type: Other
Title: DiSorin Molecular LLC Simplexa Covid-19 Direct Kits and Controls KSS201211
Source: NY State Procurement
Source ID: ny-auth-Roswell_Park_Cancer_Institute_Corporation-DiaSorin_Molecular_LLC-2021-02-08T00:00:00.000

Details

Location: NY, United States

Description

DiSorin Molecular LLC Simplexa Covid-19 Direct Kits and Controls KSS201211 Vendor: DiaSorin Molecular LLC Authority: Roswell Park Cancer Institute Corporation Type: Commodities/Supplies Award process: Authority Contract - Non-Competitive Bid MWBE: N

Dates

Publication: 2021/02/08 12:00:00 AM UTC
Closing date: 2030/12/31 12:00:00 AM UTC

Estimated value

$880K USD

How to bid

Classification

Normalized category

Other

Source: NY State Procurement

Last updated 2026-05-25, 2:13:46 p.m.

Data refreshed every 2 hours